1
Martin A Cheever, David J Peace: Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy. Washington Research Foundation, Seed and Berry, February 11, 1997: US05601989 (7 worldwide citation)

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes ...


2
Martin A Cheever, David J Peace: Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy. Washington Research Foundation, Seed and Berry, June 30, 1998: US05773230 (6 worldwide citation)

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes ...


3
Peace David J, Cheever Martin A: Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy.. Washington Res Found, September 28, 1994: EP0617124-A1

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes ...


4
Cheever Martin A, Peace David J: Immunoreactivite envers lexpression doncogenes actives pour le diagnostic et le traitement de tumeurs malignes, Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy. Washington Research Foundation, GOWLING LAFLEUR HENDERSON, August 8, 1991: CA2074720

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of Tcells in response to in vitro exposure to a protein expression product of an acivated oncogene or cancer-related gene associatedwith a malignancy, or detection of immunocomplexes for ...


5
Martin A Cheever, David J Peace: Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy. Richard G Sharkey, Seed Intellectual Property Law Group Pllc, May 1, 2003: US20030083229-A1

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes ...


6
Martin A Cheever, David J Peace: Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy. Washington Research Foundation, Seed Intellectual Property Law Group Pllc, November 25, 2004: US20040235070-A1

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an activated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes ...


7
Cheever Martin A, Peace David J: Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy. Washington Research Foundation, sSHARKEY Richard G, August 8, 1991: WO/1991/011719

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to $i(in vitro) exposure to a protein expression product of an acivated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplex ...


8
Cheever Martin A, Peace David J: Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy.. Washington Res Found, November 19, 1992: EP0513161-A1

Methods for the detection, monitoring and treatment of malignancies are disclosed. Detection of the proliferation of T cells in response to in vitro exposure to a protein expression product of an acivated oncogene or cancer-related gene associated with a malignancy, or detection of immunocomplexes f ...